1433 related articles for article (PubMed ID: 24733808)
1. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.
Hershman DL; Lacchetti C; Dworkin RH; Lavoie Smith EM; Bleeker J; Cavaletti G; Chauhan C; Gavin P; Lavino A; Lustberg MB; Paice J; Schneider B; Smith ML; Smith T; Terstriep S; Wagner-Johnston N; Bak K; Loprinzi CL;
J Clin Oncol; 2014 Jun; 32(18):1941-67. PubMed ID: 24733808
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives.
Ewertz M; Qvortrup C; Eckhoff L
Acta Oncol; 2015 May; 54(5):587-91. PubMed ID: 25751757
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Chemotherapy-Induced Peripheral Neuropathy: Systematic Review and Recommendations.
Hou S; Huh B; Kim HK; Kim KH; Abdi S
Pain Physician; 2018 Nov; 21(6):571-592. PubMed ID: 30508986
[TBL] [Abstract][Full Text] [Related]
4. Clinical inquiry: what medications are best for diabetic neuropathic pain?
Page N; Deluca J; Crowell K
J Fam Pract; 2012 Nov; 61(11):691-3. PubMed ID: 23256101
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3).
Rao RD; Michalak JC; Sloan JA; Loprinzi CL; Soori GS; Nikcevich DA; Warner DO; Novotny P; Kutteh LA; Wong GY;
Cancer; 2007 Nov; 110(9):2110-8. PubMed ID: 17853395
[TBL] [Abstract][Full Text] [Related]
6. Pregabalin and duloxetine for the treatment of neuropathic pain disorders.
Terneus W
J Pain Palliat Care Pharmacother; 2007; 21(1):79-84. PubMed ID: 17430838
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-Induced Peripheral Neuropathy: Causative Agents, Preventative Strategies, and Treatment Approaches.
Kachrani R; Santana A; Rogala B; Pawasauskas J
J Pain Palliat Care Pharmacother; 2020 Sep; 34(3):141-152. PubMed ID: 32118502
[TBL] [Abstract][Full Text] [Related]
8. Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review.
Chu SH; Lee YJ; Lee ES; Geng Y; Wang XS; Cleeland CS
Support Care Cancer; 2015 Feb; 23(2):513-24. PubMed ID: 25256375
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy-induced peripheral neuropathy: prevention and treatment.
Pachman DR; Barton DL; Watson JC; Loprinzi CL
Clin Pharmacol Ther; 2011 Sep; 90(3):377-87. PubMed ID: 21814197
[TBL] [Abstract][Full Text] [Related]
10. New Practical Approaches to Chemotherapy-Induced Neuropathic Pain: Prevention, Assessment, and Treatment.
Majithia N; Loprinzi CL; Smith TJ
Oncology (Williston Park); 2016 Nov; 30(11):1020-9. PubMed ID: 27854104
[TBL] [Abstract][Full Text] [Related]
11. Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials.
Backonja M; Glanzman RL
Clin Ther; 2003 Jan; 25(1):81-104. PubMed ID: 12637113
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis.
Rudroju N; Bansal D; Talakokkula ST; Gudala K; Hota D; Bhansali A; Ghai B
Pain Physician; 2013; 16(6):E705-14. PubMed ID: 24284851
[TBL] [Abstract][Full Text] [Related]
13. An open-label comparison of nabilone and gabapentin as adjuvant therapy or monotherapy in the management of neuropathic pain in patients with peripheral neuropathy.
Bestard JA; Toth CC
Pain Pract; 2011; 11(4):353-68. PubMed ID: 21087411
[TBL] [Abstract][Full Text] [Related]
14. [DRUG THERAPY OF NEUROPATHIC PAIN BASED ON THE LATEST RECOMMENDATIONS].
Kiss G
Ideggyogy Sz; 2015 Mar; 68(3-4):93-8. PubMed ID: 26434196
[TBL] [Abstract][Full Text] [Related]
15. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision.
Attal N; Cruccu G; Baron R; Haanpää M; Hansson P; Jensen TS; Nurmikko T
Eur J Neurol; 2010 Sep; 17(9):1113-e88. PubMed ID: 20402746
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic management of chronic neuropathic pain: an examination of pharmacologic treatment.
Vadalouca A; Siafaka I; Argyra E; Vrachnou E; Moka E
Ann N Y Acad Sci; 2006 Nov; 1088():164-86. PubMed ID: 17192564
[TBL] [Abstract][Full Text] [Related]
17. Serotonin-norepinephrine reuptake inhibitors for the management of chemotherapy-induced peripheral neuropathy.
Aziz MT; Good BL; Lowe DK
Ann Pharmacother; 2014 May; 48(5):626-32. PubMed ID: 24577146
[TBL] [Abstract][Full Text] [Related]
18. [Evidence-based pharmacotherapy of neuropathic pain syndromes].
Braune S
MMW Fortschr Med; 2004 Dec; 146(50):49-51. PubMed ID: 15658522
[TBL] [Abstract][Full Text] [Related]
19. Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.
Kuriyama A; Endo K
Support Care Cancer; 2018 Apr; 26(4):1051-1059. PubMed ID: 29280005
[TBL] [Abstract][Full Text] [Related]
20. A phase III randomized, placebo-controlled study of topical amitriptyline and ketamine for chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study of 462 cancer survivors.
Gewandter JS; Mohile SG; Heckler CE; Ryan JL; Kirshner JJ; Flynn PJ; Hopkins JO; Morrow GR
Support Care Cancer; 2014 Jul; 22(7):1807-14. PubMed ID: 24531792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
